PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells
Xinmin Zhao(Shanghai Medical College of Fudan University), Xiaolong Fu(Qingdao University)
Cited by 12
Related Papers
Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
|Advanced Science|2023|151
AAV gene therapy for autosomal recessive deafness 9: a single-arm trial
|Nature Medicine|2025|33
MicroRNA‑139‑5p improves sepsis‑induced lung injury by targeting Rho‑kinase1
|Experimental and Therapeutic Medicine|2021|15
PA-MSHA inhibits proliferation and induces apoptosis in human non-small cell lung cancer cell lines with different genotypes
|Molecular Medicine Reports|2016|11